
Solventum Corporation (SOLV) Stock Forecast & Price Target
Solventum Corporation (SOLV) Analyst Ratings
Bulls say
Solventum is a healthcare company that operates in the MedSurg, Dental Solutions, and Health Information Systems segments, with a strong focus on innovation and technology. The company has a solid financial foundation, with increasing EPS and revenue estimates, and is making strategic moves such as divesting non-core areas and implementing M&A to drive future growth. Despite some quarterly noise stemming from its spinoff from 3M, Solventum is on track to meet its long-term financial targets, making it an attractive investment opportunity.
Bears say
Solventum is expected to struggle in the near future with declining OMs, a challenging ERP cutover in the US and Canada, and the impact of tariffs on their bottom line, which could potentially be offset by contributions from their recent Acera acquisition. Furthermore, their unchanged guidance for low organic growth and lack of reassurance regarding potential refunds for tariffs suggest that their financial performance may continue to be underwhelming. These factors, along with the likelihood of continued pressure on earnings and margins from external factors, suggest a negative outlook on Solventum's stock.
This aggregate rating is based on analysts' research of Solventum Corporation and is not a guaranteed prediction by Public.com or investment advice.
Solventum Corporation (SOLV) Analyst Forecast & Price Prediction
Start investing in Solventum Corporation (SOLV)
Order type
Buy in
Order amount
Est. shares
0 shares